Myocardial Infarction (MI) Therapeutics Market is Projected to Reach USD 2.65 Billion by 2028 at a CAGR of 4.82% from 2022-2028; Increasing Burden of Cardiovascular Diseases and Innovations in Advanced Therapies Fosters Market Growth
February 22, 2023 09:50 ET
|
SkyQuest Technology Consulting Pvt. Ltd.
Westford, USA, Feb. 22, 2023 (GLOBE NEWSWIRE) -- North America is currently holding a dominant position in the myocardial infarction (MI) therapeutics market due to several factors. One of the...